Shares of Health Catalyst (HCAT) have gained 11.6% over the past four weeks to close the last trading session at $6.73, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $11.79 indicates a potential upside of 75.2%. The average comprises 14 short-term price targets ranging from a low of $8 to a high of $16, with a standard deviation of $2.72. While the lowest estimate indicates an ...

SALT LAKE CITY, May 21, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst,"Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced the launch of Health Catalyst Ignite®, a next-generation healthcare data and analytics ecosystem that combines best-in-class technologies, healthcare-specific data models, self-service tools, and industry expertise in one modern environment. Today's health systems face significant challenges in navig ...

Health Catalyst, Inc. (NASDAQ:HCAT) Q1 2024 Earnings Conference Call May 9, 2024 5:00 PM ET Company Participants Jack Knight - VP, Investor Relations Daniel Burton - CEO & Director Jason Alger - CFO Conference Call Participants Jared Haase - William Blair & Co. Elizabeth Anderson - Evercore ISI Anna Kruszenski - Barclays Capital John Ransom - Raymond James Daniel Grosslight - Citigroup Jenny Shen - BTIG Mitchell Ostrovsky - Guggenheim Securities Stan Berenshteyn - Wells Fargo & Co. Operator Good afternoon, ...

Health Catalyst (HCAT) reported $74.72 million in revenue for the quarter ended March 2024, representing a year-over-year increase of 1.2%. EPS of $0.05 for the same period compares to $0.05 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $74.81 million, representing a surprise of -0.11%. The company delivered an EPS surprise of +66.67%, with the consensus EPS estimate being $0.03.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wal ...

Health Catalyst (HCAT) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to earnings of $0.05 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 66.67%. A quarter ago, it was expected that this provider of data analytics for the health care industry would post a loss of $0.01 per share when it actually produced earnings of $0.02, delivering a surprise of 30 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________ FORM 10-Q ________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission File Number: 001-38993 HEALTH CATALYST, INC. (Exact name of registrant as specified in its charter ...

Health Catalyst Reports First Quarter 2024 Results SALT LAKE CITY, UT, May 9, 2024 — Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended March 31, 2024. "For the first quarter of 2024, I am pleased by our strong financial results, including total revenue of $74.7 million and Adjusted EBITDA of $3.4 million, with these results beating the mid-point of our q ...

Wall Street analysts expect Health Catalyst (HCAT) to post quarterly earnings of $0.03 per share in its upcoming report, which indicates a year-over-year decline of 40%. Revenues are expected to be $74.81 million, up 1.3% from the year-ago quarter.The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.Prior to a company's earnings announcement, it is crucial ...

Health Catalyst, Inc. (NASDAQ:HCAT) Q4 2023 Earnings Conference Call February 22, 2024 5:00 PM ET Company Participants Adam Brown - Senior Vice President, FP&A and Investor Relations Dan Burton - Chief Executive Officer Bryan Hunt - Chief Financial Officer Conference Call Participants Anne Samuel - JPMorgan Stephanie Davis - Barclays Jared Haase - William Blair Sameer Patel - Evercore ISI Daniel Grosslight - Citi David Larsen - BTIG Sarah James - Cantor Fitzgerald Vishal Patel - Piper Sandler John Pinney - ...

Client Engagement and Market Position - Health Catalyst has generated over 1,600 documented, client-verified improvements across clinical, financial, and operational domains, enabling substantial clinical improvements, financial savings, or operational efficiencies[36]. - Client engagement has increased as measurable improvements are delivered, leading to a broader engagement and referrals for new business[37]. - As of December 31, 2023, the company served 109 DOS Subscription Clients and over 525 other clients, primarily in the healthcare sector[38]. - The company achieved Dollar-based Retention Rates for DOS Subscription Clients of 100%, 100%, and 112% for the years ended December 31, 2023, 2022, and 2021, respectively[47]. - The company estimates its total core addressable market to include more than 1,200 healthcare organizations, indicating substantial growth opportunities[47]. - A significant portion of the company's revenue is expected to derive from the renewal of existing client contracts and sales of additional technology and services[141]. Product and Service Offerings - Health Catalyst's solution includes a cloud-based data and analytics platform, software applications, and professional services expertise tailored for healthcare organizations[18]. - The Data Operating System (DOS) platform has generated over 1,600 documented, client-verified improvements across clinical, financial, and operational domains[40]. - The company plans to continue investing in product development, particularly at the analytics applications layer of its technology stack[47]. - The company has developed an activity-based costing software application, PowerCosting, which enables CFOs and analysts to understand the true cost of clinical processes and patient outcomes[58]. - The Patient Safety Monitor application uses machine learning to predict patient safety risks, allowing clinicians to intervene proactively[58]. - The company provides a suite of population health analytics modules, including Pop Analyzer and Stratify, to support value-based care arrangements[58]. - The company’s revenue improvement solution, VitalCDM, aims to enhance operational efficiency and minimize compliance risk for hospital billing departments[62]. Team Member Engagement and Culture - The company maintains a high level of team member engagement, ranking in the 94th to 99th percentile as measured by Gallup[21]. - The company employs over 1,300 team members, with team member engagement scores consistently ranking in the 94th to 99th percentile[66][69]. - The company has received 87 recognitions as a "best place to work" from various organizations, indicating strong employee satisfaction and loyalty[69]. - The company emphasizes team member engagement as a top priority, which is believed to drive client trust and financial performance[99]. - Health Catalyst has implemented various human capital management objectives, including attracting and retaining a diverse workforce and providing opportunities for career growth[100]. - The company conducts regular team member surveys and monthly meetings to assess job satisfaction and improve retention[102]. - Health Catalyst offers market-competitive compensation, short-term bonuses, long-term equity incentives, and comprehensive benefits to its team members[103]. Financial Performance and Risks - Future financial performance is subject to various risks, including competition, technological changes, and macroeconomic challenges such as inflation and interest rates[15]. - The company’s operating model benefits from the recurring nature of its revenue, providing high revenue visibility and potential for operating leverage[41]. - The company faces intense competition in the healthcare solutions market, including from well-financed entities like Optum Analytics and IBM, which may hinder its market share[114]. - Macroeconomic challenges, including high inflation and interest rates, have adversely affected demand for the company's solutions and may lead to client bankruptcies[120]. - The company’s results of operations have historically fluctuated and may continue to do so, influenced by various external factors including macroeconomic challenges[144]. - The company recognizes technology and professional services revenue ratably over contract terms, which may delay the reflection of downturns in business in financial results[161]. - The company faces potential risks from medical malpractice claims, which could result in damage awards exceeding insurance coverage limits, adversely affecting financial condition[154]. Compliance and Regulatory Environment - The company is subject to various federal and state regulations, including those related to the corporate practice of medicine and fee-splitting laws[84]. - Compliance with evolving federal and state certification requirements is critical for maintaining the company's patient safety organization certification[85]. - The FDA regulates certain medical software, and Health Catalyst believes its marketed products are not currently classified as medical devices under FDA regulations[90]. - The company is subject to foreign regulations in countries where it operates, including the UK, India, Singapore, UAE, and Australia[95]. Technology and Cybersecurity - The DOS platform is cloud-based and primarily provided through Microsoft Azure, enhancing scalability and security[49]. - Cybersecurity risks are heightened due to reliance on internet technology and remote work, which may expose the company to potential data breaches and operational disruptions[182]. - The company’s general liability insurance may not cover all potential claims related to security breaches, exposing it to unexpected costs[186]. - The company relies on third-party vendors for Internet and telecommunications services, which increases vulnerability to service interruptions and delays[197]. - The company does not maintain redundant systems, risking extended periods of system unavailability in catastrophic events[198]. Acquisitions and Growth Strategy - The company has a track record of identifying and integrating new capabilities through acquisitions, including Medicity and Able Health[47]. - The company has acquired several businesses in recent years, including ERS in 2023, but may face challenges in integrating these acquisitions and realizing anticipated benefits[165]. - The anticipated benefits of acquisitions may not materialize, leading to potential impairment charges that could adversely affect results of operations[168]. Future Outlook and Strategic Initiatives - The company plans to hold its annual Healthcare Analytics Summit in February 2024, showcasing data-informed improvements in healthcare[70]. - The company must continue to invest in research and development to enhance existing services and introduce new applications to remain competitive[138]. - Future revenue growth may not match historical rates, with potential declines due to slower client adoption of solutions and increased competition in adjacent markets[176]. - The company faces significant uncertainty regarding the impact of the Final Rule on interoperability and information blocking, which could affect data access and market competition[188].